Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement.

CONCLUSION: The further accumulation of clinical data is needed to determine the optimal therapeutic approach for these neoplasms.
PMID: 29486661 [PubMed - as supplied by publisher]

Source: Hematology - March 1, 2018 Category: Hematology Tags: Hematology Source Type: research